Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial
Tsegahun Manyazewal(Addis Ababa University), Vincent C. Marconi(Emory University), Tewodros Getinet(St. Paul's Hospital Millennium Medical College), David P. Holland(Emory University), Kidist Bobosha(Armauer Hansen Research Institute), Belete Getahun(Federal Ministry of Health), Yimtubezinash Woldeamanuel(Addis Ababa University), Alison T. Hoover(World Education), Abebaw Fekadu(Brighton and Sussex Medical School), Oumer Fuad(Addis Ababa University)
Cited by 26
Related Papers
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Outbreak of Severe Respiratory Disease Associated with Emergent Human Adenovirus Serotype 14 at a US Air Force Training Facility in 2007
|The Journal of Infectious Diseases|2009|131
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
|The Lancet Respiratory Medicine|2022|128
Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae
|Nature Communications|2018|122
New Biomarkers with Relevance to Leprosy Diagnosis Applicable in Areas Hyperendemic for Leprosy
|The Journal of Immunology|2012|85